Roche showcases new solutions for automated molecular testing
Category: #health  By Ojaswita Kutepatil  Date: 2018-06-10
  • share
  • Twitter
  • Facebook
  • LinkedIn

Roche showcases new solutions for automated molecular testing

The Swiss multinational Roche in its recent announcement has unveiled that it will be featuring its new test options to automate molecular testing. The company reportedly will also be offering presentations on important microbiology topics encompassing MRSA screening, healthcare IT, molecular HSV testing, automating LDTs, and more from industry experts in its booth at the ASM Microbe 2018 annual conference held in Atlanta.

Sources familiar with the matter revealed that Roche for its full automated molecular testing cobas 6800 and 8800 systems will be introducing its FDA approved CT/NG test. For the record, the test will allow the research labs to combine STI testing with Roche’s viral load tests including cytomegalovirus (CMV), hepatitis B, hepatitis C, and HIV, while significantly reducing the operating time & labor.

For those uninitiated, Roche’s cobas 6800/8800 Systems are designed to offer the fastest time to results with highest throughput, coupled with the lengthiest walk-away time, that has aided lab officials to drive increased workflow efficiencies, while adapting to their continuously changing laboratory testing demands.

At the American Society for Microbiology's annual conference, the Swiss healthcare major will also be highlighting the addition of its cobas Factor II & Factor V test to its list of options for its automated cobas 4800 system. These recently cleared tests will enable laboratory staff to simultaneously assess Factor II & Factor V genetic mutations from a single sample, in turn reducing hands-on time. Sources cite that the addition to the palate will significantly allow labs to consolidate oncology, genomics, and microbiology assessment onto a single platform.

If industry experts are to be believed, Roche has designed a platform that meets the evolving needs of the modern day molecular diagnostics laboratory. These systems are further poised to set new industry standards with practical innovation for automation, throughput, and speed-of-results, that were previously not so protuberant in molecular diagnostics.



About Author

Ojaswita Kutepatil

Email: [email protected]   

Ojaswita Kutepatil

Ojaswita Kutepatil, a mechanical engineer by qualification, presently develops content for Market Size Forecasters, Algosonline, and other similar platforms. Having had a prior experience in Business Development and Technical Engineering, she now pens down articles pe...

Read More

More News By Ojaswita Kutepatil

Pepperfry to pump $12M in expansion & boost supply chain operations
Pepperfry to pump $12M in expansion & boost supply chain operations
By Ojaswita Kutepatil

The Mumbai-based online retailer also looks to step into areas like augmented/virtual reality to advance shopping experience.

Pepperfry, the online furniture & ...

Dream Incubator leads health-tech firm NIRAMAI’s Series A funding
Dream Incubator leads health-tech firm NIRAMAI’s Series A funding
By Ojaswita Kutepatil

NIRAMAI Health Analytix Pvt. Ltd., the Bengaluru-based breast cancer screening start-up, has reportedly raised around $6 million in Series A investment round that was led by Dream Incubator, a management consulting fir...

Levi Strauss plans share market comeback after more than 3 decades
Levi Strauss plans share market comeback after more than 3 decades
By Ojaswita Kutepatil

In a recent turn of events, renowned Jeans manufacturer Levi Strauss & Co has reportedly filed documents for getting listed on the New York Stock Exchange, on the lookout for returning to public markets after over ...